|
11 Feb 2025
|
Quarterly Results |
- |
|
13 Nov 2024
|
Quarterly Results |
- |
|
08 Aug 2024
|
Quarterly Results |
- |
|
27 May 2024
|
Audited Results & Dividend |
- |
|
08 Feb 2024
|
Quarterly Results |
- |
|
09 Nov 2023
|
Quarterly Results |
- |
|
14 Aug 2023
|
Quarterly Results |
- |
|
30 May 2023
|
Audited Results & Dividend |
- |
|
10 Feb 2023
|
Quarterly Results |
- |
|
11 Nov 2022
|
Quarterly Results |
- |
|
08 Aug 2022
|
Quarterly Results |
- |
|
26 May 2022
|
Audited Results & Final Dividend |
- |
|
08 Feb 2022
|
Quarterly Results |
- |
|
09 Nov 2021
|
Quarterly Results |
- |
|
09 Aug 2021
|
Quarterly Results & Interim Dividend |
- |
|
25 May 2021
|
Audited Results |
- |
|
08 Feb 2021
|
Quarterly Results |
- |
|
05 Nov 2020
|
Quarterly Results |
- |
|
10 Aug 2020
|
Quarterly Results & Interim Dividend |
- |
|
18 May 2020
|
Audited Results |
- |
|
03 Feb 2020
|
Quarterly Results |
- |
|
11 Nov 2019
|
Quarterly Results |
- |
|
07 Aug 2019
|
Quarterly Results & Interim Dividend |
- |
|
24 May 2019
|
Audited Results |
- |
|
06 Feb 2019
|
Quarterly Results |
- |
|
13 Nov 2018
|
Quarterly Results |
- |
|
13 Aug 2018
|
Unaudited Financial Results |
- |
|
21 May 2018
|
Audited Results |
- |
|
05 Feb 2018
|
Quarterly Results |
- |
|
06 Nov 2017
|
Quarterly Results |
- |
|
08 Aug 2017
|
Quarterly Results |
- |
|
09 May 2017
|
Audited Results |
- |
|
02 Feb 2017
|
Quarterly Results |
- |
|
02 Dec 2016
|
Others |
Mr. Rajesh Marwaha, Chief Financial Officer of the Company hasbeen inducted into the board as Additional and Whole-time Director. His profile is attached. |
|
11 Nov 2016
|
Quarterly Results |
- |
|
09 Aug 2016
|
Quarterly Results |
- |
|
25 May 2016
|
Audited Results |
- |
|
06 Feb 2016
|
Quarterly Results & Others |
The Board of Directors approved the re-appointment of Mr. Sanjay Murdeshwar as Managing Director of the Company for a period of 3 years, to be effective from May 02, 2016. |
|
02 Dec 2015
|
Others |
Decided to close the Active Pharmaceutical Ingredient Unit (API Unit) situated at 12th Mile on Bellary Road,Venkatala, Yelahanka, Bangalore - 560063. |
|
06 Nov 2015
|
Quarterly Results & Others |
The Board appointed Ms. Claire-Marie O' Grady as Director of the Company in the vacancy caused by the resignation of Ms. Rebekah Martin with immediate effect. |
|
04 Aug 2015
|
Quarterly Results |
- |
|
27 May 2015
|
Audited Results |
- |
|
11 Feb 2015
|
Quarterly Results |
- |
|
03 Nov 2014
|
Quarterly Results |
- |
|
12 Aug 2014
|
Quarterly Results |
- |
|
30 May 2014
|
Audited Results |
- |
|
05 May 2014
|
Others |
To consider seeking approval of shareholders of the Company through Postal Ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden,Promoter of the company. |
|
15 Apr 2014
|
Others |
To consider for the voluntary delisting proposed by AstraZeneca Pharmaceuticals Promoter of the Company, in terms of Securities and Exchange Board of India, through Postal Ballot. |
|
15 Mar 2014
|
Others |
To consider the voluntary delisting proposal from AstraZeneca Pharmaceuticals AB, Sweden in terms of their letter dated March 01, 2014 at the meeting of the BOD of the Company held on March 15,2014. |
|
05 Mar 2014
|
Others |
- |
|
10 Feb 2014
|
Quarterly Results |
- |
|
11 Nov 2013
|
Quarterly Results |
- |
|
13 Aug 2013
|
Quarterly Results |
- |
|
21 May 2013
|
Audited Results |
- |
|
06 May 2013
|
Others |
- |
|
02 May 2013
|
Quarterly Results |
- |
|
06 Feb 2013
|
Quarterly Results |
- |
|
07 Nov 2012
|
Quarterly Results |
- |
|
10 Aug 2012
|
Quarterly Results |
- |
|
11 May 2012
|
Audited & Quarterly Results |
- |
|
02 Feb 2012
|
Quarterly Results |
- |
|
10 Nov 2011
|
Quarterly Results |
- |
|
08 Aug 2011
|
Quarterly Results |
- |
|
14 Jun 2011
|
Others |
inter alia, to consider and approve the proposal of straightening of land boundaries of factory with IDL Industries Ltd. |
|
13 May 2011
|
Audited Results & Dividend |
Fifteen Months. |
|
08 Feb 2011
|
Quarterly Results |
- |
|
27 Oct 2010
|
Quarterly Results |
- |
|
27 Jul 2010
|
Quarterly Results & Others |
For seeking the consent / approval of the Shareholders of the Company through postal ballot to the delisting proposal initiated by AstraZeneca Pharmaceuticals, AB, Sweden, promoter of the Company. |
|
09 Jul 2010
|
Others |
The Board has deferred the decision on delisting proposal initiated by AstraZeneca Pharmaceuticals AB Sweden, promoter of the Company. |
|
29 Jun 2010
|
Voluntary Delisting of Shares |
To make a voluntary delisting offer to the public Shareholders of the Co. in accordance with the SEBI (DES) Regulations, 2009 with a view to delist the Equity Shares from BSE, NSE & BgSE. |
|
27 Apr 2010
|
Others |
The Board has appointed Ms. Anita Zutshi as the Chief Financial Officer of the Company. |
|
26 Apr 2010
|
Quarterly Results |
- |
|
25 Mar 2010
|
Others |
1. Proposal to augment the Co's Tablet manufacturing plant and facility involving an estimated aggregate outlay of Rs. 70 Crs. 2. Appointment of Mr. Luigi Felice La Corte, as an Additional Director. |
|
23 Feb 2010
|
Audited Results, Dividend & Others |
The Board has approved the change in the accounting year of the Company from "January-December" to "April-March" & Recommended a Dividend of Rs. 10/- per Equity Share of face value of Rs. 2/- each. |
|
27 Oct 2009
|
Quarterly Results |
- |
|
27 Jul 2009
|
Quarterly Results |
- |
|
23 Apr 2009
|
Quarterly Results |
- |
|
18 Feb 2009
|
Audited Results & Dividend |
- |
|
23 Oct 2008
|
Quarterly Results |
- |
|
29 Jul 2008
|
Quarterly Results |
- |
|
28 Apr 2008
|
Quarterly Results |
- |
|
25 Feb 2008
|
Audited Results & Dividend |
- |
|
26 Oct 2007
|
Quarterly Results |
- |
|
26 Jul 2007
|
Quarterly Results |
- |
|
30 Apr 2007
|
Quarterly Results |
- |
|
17 Mar 2007
|
Interim Dividend |
To consider the approval of the revised Audited Accounts for the financial year ended December 31, 2006, after incorporating necessary changes as to the revocation of recommended dividend & others. |
|
23 Feb 2007
|
Accounts & Dividend |
- |
|
28 Oct 2006
|
Quarterly Results |
- |
|
08 Sep 2006
|
Issue of fully paid bonus debentures |
Inter alia, to consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders |
|
28 Aug 2006
|
Issue of fully paid bonus debentures |
To consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders. (deferred) |
|
28 Jul 2006
|
Quarterly Results |
- |
|
09 May 2006
|
Sub Division of Equity shares |
- |
|
29 Apr 2006
|
Quarterly Results |
- |
|
23 Feb 2006
|
Accounts & Dividend |
- |
|
20 Oct 2005
|
Quarterly Results |
(Revised) |
|
24 Aug 2005
|
Accounts |
- |
|
27 Apr 2005
|
Quarterly Results |
- |
|
16 Feb 2005
|
Accounts & Dividend |
(Revised) |
|
30 Oct 2004
|
Quarterly Results |
- |
|
16 Aug 2004
|
Quarterly Results |
- |